Influence of Natural Lung Surfactant Inhalations on Clinical Symptoms and Pulmonary Function Parameters in Patients with Bronchial Asthma. Communication 2
Background: Damage to lung surfactant (LS) enabling the lung local immunity may contribute to the development of bronchial inflammation in patients with bronchial asthma (BA). Methods and Results: A 70-day course of 21 LS (Surfactant-BL) inhalations at the dose of 25 mg was added to inhaled cortic...
Main Authors: | E. A. Akulova, O. V. Stepanova, A. A. Seiliev, A. Ed. Shulga, O. V. Lovacheva, S. A. Lukyanov, K. G. Shapovalov, V. A. Volchkov, O. A. Rosenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
International Medical Research and Development Corporation
2017-09-01
|
Series: | International Journal of Biomedicine |
Subjects: | |
Online Access: | http://ijbm.org/articles/IJBM_7(3)_OA1.pdf |
Similar Items
-
Influence of Long-Term Inhaled Glucocorticoids on the Lung Surfactant Phospholipid Levels in Rats
by: A.A. Seiliev, et al.
Published: (2016-09-01) -
COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01) -
Surfactant therapy as a part of comprehensive treatment of asthma patients. Impact on clinical signs and external respiration rates
by: O. A. Rozenberg, et al.
Published: (2018-10-01) -
Endobronchial cryptococcosis with bronchial stenosis in a patient with severe asthma treated with inhaled corticosteroids: A case report
by: Jun Sasaki, et al.
Published: (2023-12-01) -
Comparison of the Correct Use of Different Types of Inhalers in Patients with COPD and Bronchial Asthma
by: A. A. Vizel, et al.
Published: (2023-07-01)